With the level of growth that Johnson & Johnson (JNJ) has been witnessing this year, it's coming to be one of the last companies you would associate with the word "conservative".
Traditionally, a company like Johnson & Johnson is bought for income-oriented purposes, i.e. a stable and growing dividend. Investors typically do not buy into this stock on the basis of expected share price growth.
In this regard, it's only natural to expect that a lot of debate is raging as to whether the stock is in fact too expensive to justify a buy right now.
READ FULL ARTICLE HERE